As global funding for HIV continues to face significant setbacks due to reduced international aids from donor countries, ...

Strategies that address population-specific concerns about medical mistrust and employ operational tactics, including staff ...

The Minister’s address was particularly notable for the announcement of a planned rollout of lenacapavir, a biannual ...

Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).

As global funding for HIV continues to decline due to reduced international aid from donor countries, the 7th National ...

Through a strategic, non-profit agreement, Gilead will supply up to two million doses of the long-acting HIV prevention drug ...

Gilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...

This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its ...

Shahin Davoudpour, PhD, MA, MA, talked with Physician’s Weekly about using social network strategies to improve pre-exposure prophylaxis awareness and uptake.